Potential Treatment for Nonalcoholic Steatohepatitis to Start Clinical Trials Next Year
stevepb / Pixabay

Potential Treatment for Nonalcoholic Steatohepatitis to Start Clinical Trials Next Year

According to a story from Markets Insider, the biotechnology company Innovate Biopharmaceuticals, Inc., recently announced encouraging proof-of-concept data for its lead medical product larazotide acetate. This experimental drug appears to…

Continue Reading Potential Treatment for Nonalcoholic Steatohepatitis to Start Clinical Trials Next Year
Novartis and Pfizer Join Forces to Treat Nonalcoholic Steatohepatitis
rawpixel / Pixabay

Novartis and Pfizer Join Forces to Treat Nonalcoholic Steatohepatitis

According to a story from globenewswire.com, the drug developers Pfizer and Novartis have recently announced the beginning of a collaborative effort to test new potential therapies for nonalcoholic steatohepatitis (NASH).…

Continue Reading Novartis and Pfizer Join Forces to Treat Nonalcoholic Steatohepatitis
Phase 2 Trial for an Experimental Epidermolysis Bullosa Treatment Begins Enrollment
chezbeate / Pixabay

Phase 2 Trial for an Experimental Epidermolysis Bullosa Treatment Begins Enrollment

According to a story from epidermolysisbullosanews.com, the biotechnology company TWi Biotechnology, Inc., recently announced that is has begun enrollment for its Phase 2 trial. This trial will test the company's…

Continue Reading Phase 2 Trial for an Experimental Epidermolysis Bullosa Treatment Begins Enrollment

Study Suggests That Some Scleroderma Patients Could Benefit From Stem Cell Transplant

According to a story from the Dartmouth Geisel School of Medicine, a group of researchers associated with the school recently published a study that indicated that certain scleroderma patients that…

Continue Reading Study Suggests That Some Scleroderma Patients Could Benefit From Stem Cell Transplant
Mutations are the Key to Predicting Outcomes in Myeloproliferative Neoplasms, Study Says
Katzenfee50 / Pixabay

Mutations are the Key to Predicting Outcomes in Myeloproliferative Neoplasms, Study Says

According to a story from Cure Today, a recent study has found that identifying mutations in patients with myeloproliferative neoplasms may be the key in predicting outcomes, such as disease…

Continue Reading Mutations are the Key to Predicting Outcomes in Myeloproliferative Neoplasms, Study Says
Updates on Studies Investigating Lenabasum as a Potential Treatment for Systemic Sclerosis and Dermatomyositis
stevepb / Pixabay

Updates on Studies Investigating Lenabasum as a Potential Treatment for Systemic Sclerosis and Dermatomyositis

New data has been released about the effects of lenabasum, an experimental drug, on patients with systemic sclerosis and dermatomyositis. Corbus, who are developing lenabasum, are planning to present the…

Continue Reading Updates on Studies Investigating Lenabasum as a Potential Treatment for Systemic Sclerosis and Dermatomyositis